Sponsored Links
HEADLINE STOCKS-U.S. small/midcap stocks to watch on March 9
(For large-cap stocks to watch, click on [WATCH/US])
March 9 (Reuters) - Some small and midcap stocks to watch on Tuesday:
JONES SODA CO JSDA.O, $0.50, down 40 pct
The struggling soft drink maker signed a letter of intent to be acquired by Reeds Inc REED.O in a cash-and-stock deal worth about $9.7 million. [ID:nSGE6280ED]
CERUS CORP (CERS.O), $2.67, up 13 pct
Robert W. Baird upgraded the blood safety products maker to "outperform" from "neutral," and said the market is undervaluing the company's Intercept red blood cell system. [ID:SGE6280GY]
SUSQUEHANNA BANCSHARES INC (SUSQ.O), $8.61, down 5 pct
The company on Monday said it will offer common shares to raise $300 million partly to support future acquisitions, including FDIC-assisted acquisition transactions or to pay back U.S. Treasury's funds. [ID:nSGE6270L0]
AGFEED INDUSTRIES INC FEED.O, $5.30, up 18 pct
The company reported better-than-expected full-year earnings helped by increased production volumes in the company's hog division and animal nutrition divisions. [ID:nWNAB6928]
MICROVISION INC (MVIS.O), $2.55, down 10 pct
The portable projector maker on Monday posted a narrower quarterly loss that was in line with analysts' view, but revenue fell short of market expectations. [ID:nSGE6270LL]
IMMUNOGEN INC (IMGN.O), $7.68, up 4 pct
The drugmaker said on Monday its experimental skin cancer drug received orphan drug designation from U.S. and European health regulators. [ID:nSGE6270L7]
EXELIXIS INC (EXEL.O), $6.81, Monday's close
The cancer drug developer posted a quarterly loss in line with market expectations, and forecast a full-year revenue above consensus estimates. [ID:SGE6280F5]
MATRIXX INITIATIVES MTXX.O, $4.87, Monday's close
The pharmaceuticals company said U.S. health regulators declined to withdraw the warning letter on the company's nasal versions of Zicam cold remedy. [ID:SGE6280EX] (Reporting by Mansi Dutta in Bangalore)
- Tweet this
- Link this
- Share this
- Digg this
- Reprints



Follow Reuters